Authors:
DALUGE SM
GOOD SS
FALETTO MB
MILLER WH
STCLAIR MH
BOONE LR
TISDALE M
PARRY NR
REARDON JE
DORNSIFE RE
AVERETT DR
KRENITSKY TA
Citation: Sm. Daluge et al., 1592U89, A NOVEL CARBOCYCLIC NUCLEOSIDE ANALOG WITH POTENT, SELECTIVEANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITY, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 1082-1093
Citation: Re. Dornsife et Dr. Averett, IN-VITRO POTENCY OF INHIBITION BY ANTIVIRAL DRUGS OF HEMATOPOIETIC PROGENITOR COLONY FORMATION CORRELATES WITH EXPOSURE AT HEMOTOXIC LEVELSIN HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE HUMANS, Antimicrobial agents and chemotherapy, 40(2), 1996, pp. 514-519
Citation: Ld. Condreay et al., -1-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE (524W91) INHIBITS HEPATITIS-B VIRUS-REPLICATION IN PRIMARY HUMAN HEPATOCYTES, Antimicrobial agents and chemotherapy, 40(2), 1996, pp. 520-523
Authors:
PREUGSCHAT F
AVERETT DR
CLARKE BE
PORTER DJT
Citation: F. Preugschat et al., A STEADY-STATE AND PRE-STEADY-STATE KINETIC-ANALYSIS OF THE NTPASE ACTIVITY ASSOCIATED WITH THE HEPATITIS-C VIRUS NS3 HELICASE DOMAIN, The Journal of biological chemistry, 271(40), 1996, pp. 24449-24457
Authors:
NAIR V
STCLAIR MH
REARDON JE
KRASNY HC
HAZEN RJ
PAFF MT
BOONE LR
TISDALE M
NAJERA I
DORNSIFE RE
AVERETT DR
BORROTOESODA K
YALE JL
ZIMMERMAN TP
RIDEOUT JL
Citation: V. Nair et al., ANTIVIRAL, METABOLIC, AND PHARMACOKINETIC PROPERTIES OF THE ISOMERIC DIDEOXYNUCLEOSIDE -AMINO-9H-PURIN-9-YL)TETRAHYDRO-2(S)-FURANMETHANOL, Antimicrobial agents and chemotherapy, 39(9), 1995, pp. 1993-1999
Authors:
KELLEY JL
MCLEAN EW
CROUCH RC
AVERETT DR
TUTTLE JV
Citation: Jl. Kelley et al., [[(GUANINYLALKYL)PHOSPHINICO]METHYL]PHOSPHONIC ACIDS - MULTISUBSTRATEANALOG INHIBITORS OF HUMAN ERYTHROCYTE PURINE NUCLEOSIDE PHOSPHORYLASE, Journal of medicinal chemistry, 38(6), 1995, pp. 1005-1014
Authors:
DALUGE SM
PURIFOY DJM
SAVINA PM
STCLAIR MH
PARRY NR
DEV IK
NOVAK P
AYERS KM
REARDON JE
ROBERTS GB
FYFE JA
BLUM MR
AVERETT DR
DORNSIFE RE
DOMIN BA
FERONE R
LEWIS DA
KRENITSKY TA
Citation: Sm. Daluge et al., 5-CHLORO-2',3'-DIDEOXY-3'-FLUOROURIDINE (935U83), A SELECTIVE ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS AGENT WITH AN IMPROVED METABOLIC AND TOXICOLOGICAL PROFILE, Antimicrobial agents and chemotherapy, 38(7), 1994, pp. 1590-1603
Authors:
PAFF MT
AVERETT DR
PRUS KL
MILLER WH
NELSON DJ
Citation: Mt. Paff et al., INTRACELLULAR METABOLISM OF (-) AND -1-[2(HHYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE IN HEPG2 DERIVATIVE 2.2.15 (SUBCLONE P5A) CELLS()), Antimicrobial agents and chemotherapy, 38(6), 1994, pp. 1230-1238
Authors:
VANDRAANEN NA
TISDALE M
PARRY NR
JANSEN R
DORNSIFE RE
TUTTLE JV
AVERETT DR
KOSZALKA GW
Citation: Na. Vandraanen et al., INFLUENCE OF STEREOCHEMISTRY ON ANTIVIRAL ACTIVITIES AND RESISTANCE PROFILES OF DIDEOXYCYTIDINE NUCLEOSIDES, Antimicrobial agents and chemotherapy, 38(4), 1994, pp. 868-871
Authors:
CONDREAY LD
JANSEN RW
POWDRILL TF
JOHNSON LC
SELLESETH DW
PAFF MT
DALUGE SM
PAINTER GR
FURMAN PA
ELLIS MN
AVERETT DR
Citation: Ld. Condreay et al., EVALUATION OF THE POTENT ANTI-HEPATITIS-B VIRUS AGENT -1-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE IN A NOVEL IN-VIVO MODEL, Antimicrobial agents and chemotherapy, 38(3), 1994, pp. 616-619
Authors:
FOUREL I
CULLEN JM
SAPUTELLI J
ALDRICH CE
SCHAFFER P
AVERETT DR
PUGH J
MASON WS
Citation: I. Fourel et al., EVIDENCE THAT HEPATOCYTE TURNOVER IS REQUIRED FOR RAPID CLEARANCE OF DUCK HEPATITIS-B VIRUS DURING ANTIVIRAL THERAPY OF CHRONICALLY INFECTED DUCKS, Journal of virology, 68(12), 1994, pp. 8321-8330
Authors:
CHAMBERLAIN SD
BIRON KK
DORNSIFE RE
AVERETT DR
BEAUCHAMP L
KOSZALKA GW
Citation: Sd. Chamberlain et al., AN ENANTIOSPECIFIC SYNTHESIS OF THE HUMAN CYTOMEGALOVIRUS ANTIVIRAL AGENT -OXO-9H-PURIN-9-YL)METHOXY)HYDROXYBUTYL]PHOSPHONIC ACID, Journal of medicinal chemistry, 37(9), 1994, pp. 1371-1377